Cancer can be characterized as a disease where an uncontrollably growing group of abnormal cells disregarding the normal mechanism of cell division. The healthy cells that are continuously subject to stimuli that determine whether the cell will reproduce, differentiate or die. Cancer cells experience a degree of autonomy from these signals, resulting in uncontrolled growth and proliferation and metastasis. There are over 200 different cancer forms. The sequence, predicting a dominant autosomal gene that resulted in an increased risk of developing breast cancer, was published the same year as the cloned BRCA1 gene. Different model has used cancer and steroid hormone evidence to determine the risk of breast cancer in women with family history of cancer of the breast. There are over sixty different organs in the body that can develop cancer from nearly any cell type in the body. As a result, more than 150 ongoing clinical trials are being conducted that investigate the efficacy of nanotechnological drug carrires which target cancer have developed quickly into the nanotechnology field.
Cite this article:
Akshay R. Yadav, Shrinivas K. Mohite. Cancer- A Silent Killer: An Overview. Asian J. Pharm. Res. 2020; 10(3):213-216. doi: 10.5958/2231-5691.2020.00036.2
Akshay R. Yadav, Shrinivas K. Mohite. Cancer- A Silent Killer: An Overview. Asian J. Pharm. Res. 2020; 10(3):213-216. doi: 10.5958/2231-5691.2020.00036.2 Available on: https://asianjpr.com/AbstractView.aspx?PID=2020-10-3-12
1. Halliday A, Human Cancer Classification: A Systems Biology- Based Model Integrating Morphology, Cancer Stem Cells, Proteomics, and Genomics. Journal of Cancer. 2011; 2:107-115.
2. Shah R, Rosso K, Nathanson D. Pathogenesis, prevention, diagnosis and treatment of breast cancer. World Journal of W J C O Clinical Oncology. 2014; 5(3): 283-298.
3. William C. Recent Advances in the Treatment of Breast Cancer. Frontiers oncology. 2018; 8: 227.
4. Sharma G, Dave R, Sanadya J, Sharma P, Sharma K. Various types and management of breast cancer: an overview. Journal of Advanced Nanotechnology and Research. 2010; 1(2): 109–126.
5. Harsh M. Textbook of Pathology. Jaypee Brothers Medical Publishers. 2010; 6: 130-132.
6. Kunda M. Synthesis and anticancer activity of 3, 5 diaryl- 1, 2, 4 oxadiazole derivative. Indian Journal of Chemistry. 2012; 51: 493-497.
7. Mirian M. Synthesis and Cytotoxic Evaluation of Some Novel Sulfonamide Derivatives against a Few Human Cancer Cells. Iranian Journal of Pharmaceutical Research.2011; 10: 741-748.
8. Holla S. Synthesis and anticancer activity studies on some 2-chloro-1, 4-bis–(5substituted-1, 3, 4-oxadiazol-2-yl methyleneoxy) phenylene derivatives. Indian Journal of Chemistry. 2003; 44: 1669-1673.
9. Florence A. In Vitro Anticancer Activity of Gmelina Asiatica L. Leaf against Human Breast Cancer Cell Line (Mcf-7). International Journal Pharmaceutical Sciences and Reserach. 2016; 7: 2116-2121.
10. Patel S. In- Vitro cytotoxicity activity of solanumnigrum extract against hell cell line and vitro cell line. International Journal Pharmaceutical Science. 2009; 1: 39-46.
11. Saulo F, Pinto B, Nayara C, Jonas P, Elaine M, S. Renata. Synthesis and cytotoxicity evaluation of thiosemicarbazones and their thiazole derivatives. Journal of Brazilian of Pharmaceutical Science. 2016; 52: 299-307.
12. Girish V, Rekha N, Lakshmi R. Synthesis and evaluation of antiangiogenic and anticancer properties of noveloxadaizole analogue.” International Research Journal of Pharmacy. 2014; 5(6): 489-494.
13. Adimule V, Medapa V, Kumar L, Rao P. Design, Synthesis, Characterization and Anticancer Properties of Novel 2-Chloro-N-(Aryl Substituted) Acetamide Derivatives of 5-[2-(4- Methoxyphenyl) Pyridin-3-yl]-1, 3, 4-Oxadiazole-2-Thiol. 2014; 6(4): 188-195.
14. Rasool I, Ahmad M, Khan Z, Mansha A, Maqbool T, Zahoor AF, Aslam S. Recent Advancements in Oxadiazole-Based Anticancer Agents. Topical Journal of Pharmaceutical Research. 2017; 16(3): 7223-733.
15. Khalil N, Kamal A, Emam S. Design, Synthesis and Antitumor Activity of Novel 5-Pyridyl-1,3,4-Oxadiazole Derivatives Against the Breast Cancer Cell Line MCF-7. The Pharmaceutical Society of Japan. 2015; 38(5): 763-773.
16. Asirvatham R, Christina A, Murali A. In Vitro Antioxidant and Anticancer Activity Studies on DroseraIndica L. (Droseraceae). Advanced Pharmaceutical Bulletin. 2013; 3(1): 115-120.
17. Gunasekaran S, Kumar V, Shanmugasokan L, Pitchai S, Yesudas R, Chacko A. Screening of in vitro cytotoxic activity of brown seaweeds against hepatocellular carcinoma. Journal of Applied Pharmaceutical Science. 2017; 7(05): 51-55.
18. Veni A, Mohandass S. In-vitro Cytotoxic Activity of Enicostemmaaxillare Extract against Hela Cell Line. International Journal of Pharmacognosy and Phytochemical Research. 2014; 6(2): 320-323.
19. Lagas M, Santiago L, Ramos J. Cytotoxicity and Apoptotic Activity of Ficus pseudopalma Blanco Leaf Extracts against Human Prostate Cancer Cell Lines. Tropical Journal of Pharmaceutical Research. 2014; 13(1): 93-100.